In company trials, the weight-loss medication Zepbound reduces sleep apnea.

Published Date: 24 Apr 2024

In two corporate trials, obese adults with sleep apnea experienced less discomfort from Zepbound, one of the immensely popular weight-loss medications that millions of Americans currently take, the pharmaceutical company Eli Lilly reported on Wednesday.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Q&A: When will individuals be able to receive customized cancer vaccines?

2.

Canadian Group Calls for Earlier Colorectal Cancer Screening

3.

Children living near oil and gas wells face higher risk of rare leukemia, studies show

4.

Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.

5.

Talquetamab Combos Show Survival Benefit in r/r Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot